 PITTSBURGH, Sept. 29, 2022 GLOBE NEWSWIRE -- Krystal Biotech, Inc. the Company NASDAQ: KRYS, the leader in redosable gene therapy, announced today that the Company will participate in the Chardans 6th Annual Genetic Medicines Conference in New York from October 3-4. 